Section Arrow
BVS.NASDAQ
- Bioventus
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 10.07
+0.19 (+1.92%)
Bid
9.89
Ask
9.9
High 10.07 
Low 9.8 
Volume 11.44K 
Regular Hours (Closed)
Last
 9.88
-0.07 (-0.70%)
Day High 
10.17 
Prev. Close
9.95 
1-M High
15.33 
Volume 
612.43K 
Bid
9.89
Ask
9.9
Day Low
9.81 
Open
9.85 
1-M Low
9.91 
Market Cap 
681.32M 
Currency 美元 
P/E 12.28 
%Yield -- 
10-SMA 10.69 
20-SMA 12 
50-SMA 12.87 
52-W High 15.8927 
52-W Low 7.015 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.81/0.89
Enterprise Value
960.27M
Balance Sheet
Book Value Per Share
3.51
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
568.09M
Operating Revenue Per Share
7.34
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.